Hinge Health, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Hinge Health, Inc. announced a 53% year-over-year revenue increase for the second quarter of 2026, alongside significant improvements in gross margin, driven by operational efficiencies and reduced stock-based compensation.
NYSE
Hinge Health, Inc. announced a 47% year-over-year revenue increase for the first quarter of 2026, driven by strong client retention and member growth.
NYSE
Hinge Health, Inc. reports a 53% revenue increase for Q3 2025, reaching $154.2 million, alongside a significant widening of net loss to $560.4 million for the nine months ended September 30, 2025, primarily due to IPO-related stock-based compensation.
NYSE
Hinge Health, Inc. announced significant revenue growth and positive cash flow in its latest quarterly report, despite a substantial net loss driven by IPO-related stock-based compensation.